World's Best Scientists 2026 revealed!
Stefan Gesk

Stefan Gesk

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
9585
World Ranking
13418
National Ranking
953

Overview

Stefan Gesk is affiliated with Kiel University in Germany and works primarily in the field of Medicine. Their research spans various subfields, including Oncology, Pathology and Forensic Medicine, Genetics, Surgery, and Oral Surgery.

The scientific contributions of Stefan Gesk are reflected in research topics such as:

  • Viral-associated cancers and disorders
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Salivary Gland Tumors Diagnosis and Treatment
  • Oral and Maxillofacial Pathology
  • Bone Tumor Diagnosis and Treatments

Recent papers authored or co-authored by Stefan Gesk include:

  • "Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing," Blood Cancer Journal, 2021
  • "Outcome of Ordinary Polymorphous Adenocarcinomas of the Salivary Glands in Comparison With Papillary and Cribriform Subtypes," Anticancer Research, 2022

These publications contribute to advancing the understanding of lymphoma and salivary gland tumors through genomic analysis and clinical outcome comparisons.

Stefan Gesk collaborates frequently with a number of co-authors, including:

  • Niklas Gebauer
  • Axel Künstner
  • Julius Ketzer
  • Hanno M. Witte
  • Tobias Rausch

Their work has been published in specialized journals such as:

  • Blood Cancer Journal
  • Anticancer Research

The diversity of research focus areas-from genetics through surgical subfields-indicates an interdisciplinary approach in addressing complex medical conditions, particularly those related to cancer and tumor pathology.

Best Publications

  • Cyclin D1-negative mantle cell lymphoma : a clinicopathologic study based on gene expression profiling

    Kai Fu;Dennis D. Weisenburger;Timothy Charles Greiner;Sandeep Dave

  • TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

    Roland Schmitz;Martin-Leo Hansmann;Verena Bohle;Jose Ignacio Martin-Subero

  • FISH Analysis for the Detection of Lymphoma-Associated Chromosomal Abnormalities in Routine Paraffin-Embedded Tissue

    Roland A. Ventura;Jose I. Martin-Subero;Margaret Jones;Joanna McParland

  • Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome

    Reinhard Schneppenheim;Michael C. Frühwald;Stefan Gesk;Martin Hasselblatt

  • Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy

    José M. Morante-Redolat;Ana Gorostidi-Pagola;Salomé Piquer-Sirerol;Amets Sáenz

  • The BCL11 gene family: involvement of BCL11A in lymphoid malignancies.

    Ed Satterwhite;Takashi Sonoki;Tony G. Willis;Lana Harder

  • Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.

    José I Martín-Subero;Stefan Gesk;Lana Harder;Takashi Sonoki

  • Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol.

    Gunnar Cario;Martin Zimmermann;Renja Romey;Stefan Gesk

  • Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.

    Stefan Joos;Christiane K. Menz;Gunnar Wrobel;Reiner Siebert

  • Translocations activating IRF4 identify a subtype of germinal-center-derived B-cell lymphoma affecting predominantly children and young adults

    Itziar Salaverria;Claudia Philipp;Ilske Oschlies;Christian W. Kohler

  • Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression

    Martin Hasselblatt;Stefan Gesk;Florian Oyen;Sabrina Rossi

  • Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

    Takashi Akasaka;Theodore Balasas;Lisa J Russell;Kei-ji Sugimoto

  • Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene.

    Lan Kluwe;Reiner Siebert;Stefan Gesk;Reinhard E. Friedrich

  • Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes

    Fanny Rubio-Moscardo;David Blesa;Cinta Mestre;Reiner Siebert

  • Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.

    Marta Salido;Cristina Baró;David Oscier;Kostas Stamatopoulos

  • Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies

    Takashi Sonoki;Lana Harder;Doug E. Horsman;Loraine Karran

  • MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.

    Hongtao Ye;Liping Gong;Liping Gong;Hongxiang Liu;Rifat A. Hamoudi

  • Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes.

    Douglas E. Horsman;Ichiro Okamoto;Olga Ludkovski;Nhu Le

  • A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms

    Jose Ignacio Martin-Subero;Ole Ammerpohl;Marina Bibikova;Eliza Wickham-Garcia

  • Clinicopathologic Correlations of Genomic Gains and Losses in Follicular Lymphoma

    Andreas Viardot;Peter Möller;Josef Högel;Kirsten Werner

Frequent Co-Authors

Reiner Siebert
Reiner Siebert University of Ulm
Martin J. S. Dyer
Martin J. S. Dyer University of Leicester
Wolfram Klapper
Wolfram Klapper Kiel University
José I. Martín-Subero
José I. Martín-Subero University of Barcelona
Ralf Küppers
Ralf Küppers University of Duisburg-Essen
María José Calasanz
María José Calasanz University of Navarra
Brigitte Schlegelberger
Brigitte Schlegelberger Hannover Medical School
Martin Dreyling
Martin Dreyling Ludwig-Maximilians-Universität München
Thomas F. E. Barth
Thomas F. E. Barth University of Ulm
Peter Møller
Peter Møller University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Biology or Biochemistry opens doors to a range of related online programs and professional opportunities. Many students now explore advanced healthcare careers through flexible formats, including an msn to dnp online no clinicals pathway—ideal for professionals aiming to move into leadership without onsite clinical hours.

Those interested in management within healthcare can consider an online phd in healthcare management. This degree prepares you for executive and academic roles, focusing on systems, policy, and administration.

Alternatively, individuals wishing to pivot to pharmacy from a science foundation can explore online pharmd programs for non pharmacists. These programs provide tailored coursework for non-pharmacy graduates seeking entry into the profession.

For students more interested in fitness, health, or sports, an exercise science online degree can lead to diverse careers in wellness, coaching, and rehabilitation fields.

Exploring these online pathways expands your career options beyond traditional Biology or Biochemistry roles, mixing science with leadership, patient care, or fitness expertise.

Best Scientists Citing Stefan Gesk

Trending Scientists